1. Home
  2. TEI vs QTRX Comparison

TEI vs QTRX Comparison

Compare TEI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TEI

Templeton Emerging Markets Income Fund Inc.

HOLD

Current Price

$6.60

Market Cap

311.2M

Sector

Finance

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$6.47

Market Cap

306.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEI
QTRX
Founded
1993
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
311.2M
306.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
TEI
QTRX
Price
$6.60
$6.47
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$11.33
AVG Volume (30 Days)
142.4K
622.5K
Earning Date
01-01-0001
03-16-2026
Dividend Yield
10.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$130,203,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$28.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$4.05
52 Week High
$5.39
$10.28

Technical Indicators

Market Signals
Indicator
TEI
QTRX
Relative Strength Index (RSI) 54.80 43.71
Support Level $6.55 $6.84
Resistance Level $6.68 $7.45
Average True Range (ATR) 0.07 0.57
MACD -0.00 -0.05
Stochastic Oscillator 64.58 2.95

Price Performance

Historical Comparison
TEI
QTRX

About TEI Templeton Emerging Markets Income Fund Inc.

Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Share on Social Networks: